Outset Medical Files 8-K on Shareholder Vote Matters

TL;DR

Outset Medical held a shareholder vote on May 29th, details to follow.

AI Summary

Outset Medical, Inc. filed an 8-K on May 30, 2024, reporting on matters submitted to a vote of security holders as of May 29, 2024. The filing does not detail the specific matters voted upon or the outcome of the vote.

Why It Matters

This filing indicates that Outset Medical held a vote of its security holders, which could pertain to significant corporate actions or governance changes that may impact the company's future direction.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.

Key Players & Entities

• Outset Medical, Inc. (company) — Registrant
• May 29, 2024 (date) — Date of earliest event reported
• May 30, 2024 (date) — Date of report

FAQ

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value per share OM The Nasdaq S

Filing Documents

• om-20240529.htm (8-K) — 63KB
• 0000950170-24-066561.txt ( ) — 180KB
• om-20240529.xsd (EX-101.SCH) — 29KB
• om-20240529_htm.xml (XML) — 4KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On May 29, 2024, Outset Medical, Inc. (the " Company ") held its Annual Meeting of Stockholders at 1:30 p.m. Pacific Time in a virtual format via live audio webcast (the " Annual Meeting "). As of April 2, 2024, the Company's record date, there were a total of 51,702,159 shares of common stock outstanding and entitled to vote at the Annual Meeting. At the beginning of the Annual Meeting, 38,482,261 shares of common stock were present virtually in person or by proxy, and, therefore, a quorum was present. Three items of business were acted upon by the stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below. Proposal One: Election of Class I Directors Each of Karen Drexler, Dale E. Jones and Leslie Trigg was elected to serve as a class I director to hold office until the Company's 2027 annual meeting of stockholders and until the election and qualification of his or her successor. Votes were cast as follows: For Withheld Broker Non-Votes Karen Drexler 25,813,322 7,579,904 5,089,035 Dale E. Jones 32,551,383 841,843 5,089,035 Leslie Trigg 32,066,397 1,326,829 5,089,035 Since the Board is divided into three classes with one class elected each year to hold office for a three-year term, the following directors continued to serve as directors of the Company immediately after the Annual Meeting: D. Keith Grossman, Patrick T. Hackett, Jim Hinrichs, Brent D. Lang and Andrea L. Saia. Proposal Two: Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2023 compensation of the Company's named executive officers as disclosed in its 2024 proxy statement on a non-binding advisory basis was approved by the following vote: For Against Abstain Broker Non-Votes 16,832,317 16,462,009 98,900 5,089,035 Proposal Three: Ratification of Appointment of Independent Registered Public Accounti

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Outset Medical, Inc. Date: May 30, 2024 By: /s/ John Brottem John Brottem General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR